Cite
HARVARD Citation
Allen, C. et al. (2017). The impact of regulatory action on the co‐prescribing of renin–angiotensin system blockers in UK primary care†. Pharmacoepidemiology and drug safety. 26 (7), pp. 858-862. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Allen, C. et al. (2017). The impact of regulatory action on the co‐prescribing of renin–angiotensin system blockers in UK primary care†. Pharmacoepidemiology and drug safety. 26 (7), pp. 858-862. [Online].